Author Topic: Novartis Plans $23B Investment in US Facilities as Trump Threatens Pharma Tariffs  (Read 54 times)

0 Members and 1 Guest are viewing this topic.

Offline Free Vulcan

  • Technical
  • *****
  • Posts: 16,653
  • Gender: Male
  • Ah, the air is so much fresher here...


Swiss pharmaceutical giant Novartis (NVS) said it plans to invest $23 billion in the construction and expansion of 10 U.S. facilities, as drugmakers brace for potential tariffs from the Trump administration.

The planned investment includes six new manufacturing plants and a San Diego-based research and development site to be built over the next five years. Two of the six plants, which Novartis said will manufacture cancer therapies, are slated to be built in Florida and Texas.
1
PR Newswire. “Novartis plans to expand its US-based manufacturing and R&D footprint with a total investment of $23B over the next 5 years.”


Novartis said it expects the projects to create more than 4,000 American jobs, including 1,000 roles at the company.

https://www.investopedia.com/novartis-plans-usd23b-investment-in-us-facilities-as-trump-threatens-pharma-tariffs-11713217
The Republic is lost.